D059005Chemicals & DrugsD27.505.519.389.892.750D27.505.954.248.794.75015260.991124Topoisomerase II Inhibitorsprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson17613328Gombos DS, Hungerford J, Abramson DH, Kingston J, Chantada G, Dunkel IJ, Antoneli CB, Greenwald M, Haik BG, Leal CA, Medina-Sanson A, Schefler AC, Veerakul G, Wieland R, Bornfeld N, Wilson MW, Yu CBOphthalmologySecondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor? Ophthalmology. 2007 Jul; 114(7):1378-83.Ophthalmology2007-07-01T00:00:002007Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?Radiation & Cellular OncologyMedicine-Hematology and Oncology19464879Yong WP, Kim TW, Undevia SD, Innocenti F, Ratain MJEuropean journal of cancer (Oxford, England : 1990)R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9. Eur J Cancer. 2009 Jul; 45(11):1904-8.Eur J Cancer2009-05-21T00:00:002009R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9.0.6842930.007355715research area of0.357110.01848634subject area forhttp://www.pgrn.org/pgx-of-chemotherapeutic-toxicities.htmlMy Lab ObjectivesMedicineUniversity of ChicagoNancy JeanCox2WFmE4EXCuiXhHlsaUXv9Gq0+s+oNancy Jean Cox41.78927490000000-87.601250000000001011Cox, Nancy JeanEmeritus/EmeritaRichard A.LarsonRichard A. Larson41.78927490000000-87.601250000000001169Larson, Richard A.ProfessorMark J.RatainMark J. Ratain41.78927490000000-87.601250000000001401Ratain, Mark J.ProfessorDavidGrdinaDavid Grdina41.78927490000000-87.60125000000000255Grdina, DavidProfessorMary EileenDolan2mdtBK0UF8zMknJtY0fp/Cv/+94=Mary Eileen Dolan41.78927490000000-87.601250000000002594Dolan, Mary EileenProfessortrue1Emeritus/EmeritaEmeritus/Emeritatrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor19176392Rao VA, Klein SR, Agama KK, Toyoda E, Adachi N, Pommier Y, Shacter EBCancer researchThe iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells. Cancer Res. 2009 Feb 01; 69(3):948-57.Cancer Res2009-01-27T00:00:002009The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells.19285952Toyoda E, Kurosawa A, Kamekawa H, Adachi NBiochemical and biophysical research communicationsTopoisomerase IIalpha inhibition following DNA transfection greatly enhances random integration in a human pre-B lymphocyte cell line. Biochem Biophys Res Commun. 2009 May 08; 382(3):492-6.Biochem Biophys Res Commun2009-03-13T00:00:002009Topoisomerase IIalpha inhibition following DNA transfection greatly enhances random integration in a human pre-B lymphocyte cell line.18596031Toyoda E, Kagaya S, Cowell IG, Kurosawa A, Kamoshita K, Nishikawa K, Iiizumi S, Koyama H, Austin CA, Adachi NThe Journal of biological chemistryNK314, a topoisomerase II inhibitor that specifically targets the alpha isoform. J Biol Chem. 2008 Aug 29; 283(35):23711-20.J Biol Chem2008-07-02T00:00:002008NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform.